forgemax.FORGED. TESTED. PROVEN.
Ment 100mg/ml 10ml Vial by Master Pharma
Purity Tested

Ment 100mg/ml 10ml Vial by Master Pharma

Master Pharma Ment delivers Trestolone Acetate at 100mg/ml — the highest concentration in this product group — across a 10ml multi-dose vial engineered for athletes who build their training blocks around structured anabolic cycles. Because Trestolone Acetate's short acetate ester supports rapid plasma accumulation, training volume and intensity can be periodized to match the compound's concentration curve from week one. Batch release is conditional on two analytical gates: reversed-phase HPLC potency verification against a certified Trestolone reference standard, and LAL endotoxin clearance — both results documented on the lot-specific Certificate of Analysis.

€48.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Supports progressive overload from week one due to rapid plasma accumulation
  • 100mg/ml concentration — highest in the product group — enables precise microdose programming
  • Short acetate ester allows training periodization to begin earlier than with long esters
  • HPLC-verified potency ensures dose arithmetic for training adjustments is analytically confirmed
  • 10ml multi-dose vial format suits daily or every-other-day injection protocols across a full cycle
  • LAL endotoxin clearance on every batch supports safe parenteral administration throughout the training block
  • Lot-specific Certificate of Analysis available on request for full transparency

Key takeaways

  • Periodize training volume to match the compound's three-phase plasma arc.
  • Increase session frequency to four–six days when injecting daily or EOD.
  • Reduce volume during intensification phase to support heavier absolute loads.
  • Use 100mg/ml concentration for precise insulin-syringe microdose calculations.
  • Confirm each batch's potency via the lot-specific Certificate of Analysis.

Trestolone Acetate as a Cycle-Structuring Tool

Master Pharma Ment is a single-ingredient injectable preparation in which Trestolone Acetate — a 7α-methyl-19-nortestosterone derivative — provides the anabolic stimulus around which progressive training blocks are designed. Unlike longer-esterified androgens that require multi-week lead times before systemic levels are sufficient to support meaningful training overload, the acetate ester's rapid hydrolysis means athletes can begin escalating weekly volume within the first seven to ten days of the cycle. Compared to testosterone enanthate-based cycles, where peak plasma levels typically emerge around week three, a Trestolone Acetate protocol allows training periodization to start earlier and compress the productive overload phase into a shorter calendar window.

Programming Volume and Intensity Across the Cycle Arc

Effective cycle-integrated training follows a three-phase logic. During the accumulation phase (weeks one to three), compound lifts with moderate volume — 15–20 working sets per muscle group per week — build the foundation as plasma Trestolone rises. The intensification phase (weeks four to seven) shifts the emphasis toward heavier loading and reduced redundancy: weekly volume can drop to 12–16 sets while intensity increases, taking advantage of the elevated androgen-receptor activation that Trestolone Acetate produces through its potent AR-binding affinity. In the final week before cycle conclusion, a brief deload of eight to ten sets per muscle group preserves connective tissue integrity and positions the athlete for productive PCT-phase training.

Purity-Tested Concentration Supporting Accurate Dose-to-Volume Calculations

At 100mg/ml, Master Pharma Ment allows precise insulin-syringe microdosing — a practical advantage when daily or every-other-day injection protocols are used to keep plasma levels stable throughout the training week. Master Pharma verifies every production batch by reversed-phase HPLC, with quantification performed against a certified external Trestolone Acetate reference standard; the resulting potency figure is recorded on the lot Certificate of Analysis and made available to purchasers on request. LAL endotoxin screening provides a second independent release criterion, ensuring parenteral safety thresholds are met before distribution is authorised. Consistent, analytically confirmed concentration means dose arithmetic for training-phase adjustments is reliable rather than estimated.

Usage

  1. Calculate your weekly dose in advance using the 100mg/ml concentration — write the exact volume (ml) per injection before drawing to avoid arithmetic errors during the cycle.
  2. Establish your injection schedule (daily or every-other-day) at the start of week one and adhere to it throughout the cycle to maintain consistent plasma androgen levels aligned with your training days.
  3. Draw the required volume using a 1ml insulin syringe under strict aseptic technique; swab the vial septum with an alcohol wipe before every draw.
  4. Rotate injection sites (glutes, quads, delts) on a structured rotation log — frequent injection schedules increase site stress, and rotation prevents localised fibrosis during longer cycles.
  5. Adjust training volume each week according to the three-phase programming model: build in weeks one to three, intensify in weeks four to seven, deload in the final week.
  6. After each injection session, record the dose, site, and session RPE (Rate of Perceived Exertion) in a cycle log — cross-referencing training response with injection timing helps identify the most productive injection-to-training window for future cycles.

Warnings

Contraindications: Not for use by individuals under 21, women of childbearing potential, or anyone with existing prostate pathology, polycythemia, or androgen-sensitive malignancy. Cardiovascular disease, hepatic impairment, or uncontrolled hypertension are absolute contraindications.

Side Effects: Trestolone Acetate aromatizes at a rate exceeding testosterone, making estrogenic side effects — including gynecomastia and water retention — a primary concern. Androgenic effects (acne, accelerated scalp hair thinning) and suppression of endogenous testosterone production are expected at therapeutic doses. Elevated hematocrit and lipid profile shifts require monitoring throughout the cycle.

Monitoring: Obtain baseline bloodwork (full blood count, lipid panel, estradiol, LH, FSH, hematocrit) before cycle commencement. Repeat at the midpoint of the intensification phase and at cycle conclusion. Estradiol management with an aromatase inhibitor should be titrated based on serum values, not symptom perception alone.

PCT: Because Trestolone Acetate produces pronounced HPG-axis suppression, PCT with a SERM (clomiphene or tamoxifen) is mandatory. Initiate PCT 48–72 hours after the final injection given the short acetate ester clearance time. A standard four-week SERM protocol is a minimum; bloodwork at PCT completion confirms axis recovery before training load is escalated again.

Frequently asked questions

How should I structure my training program during a Trestolone Acetate cycle?
Structure the cycle in three distinct training blocks: an accumulation phase with moderate volume in weeks one to three, an intensification phase with heavier loading in weeks four to seven, and a brief deload in the final week. This mirrors the compound's plasma concentration arc, allowing progressive overload to align with rising androgen levels rather than running a flat program throughout.
What weekly training volume is appropriate at the peak of a Trestolone Acetate cycle?
During the intensification phase — roughly weeks four to seven — 12 to 16 working sets per muscle group per week is a well-tolerated range for most intermediate athletes. Volume is deliberately reduced relative to the accumulation phase so heavier absolute loads can be handled safely, with connective tissue recovery kept in check as androgen levels peak.
How do I adjust training frequency to match the short half-life of Trestolone Acetate?
Because the acetate ester produces relatively stable day-to-day plasma levels when injected daily or every other day, higher training frequencies — four to six sessions per week — are sustainable and appropriate. This suits full-body or upper/lower splits that spread mechanical stimulus across frequent sessions, matching the compound's consistent anabolic signalling rather than relying on infrequent high-volume days.
How do I dose Master Pharma Ment 100mg/ml accurately using an insulin syringe?
At 100mg/ml, a standard 1ml insulin syringe draws exactly 100mg per full barrel, making fractional doses straightforward: 0.5ml = 50mg, 0.25ml = 25mg. This is the highest concentration in the Trestolone Acetate product group, so smaller injection volumes deliver the same dose compared to lower-concentration alternatives — reducing site discomfort on frequent injection schedules.
What are the storage requirements for the Master Pharma Ment 10ml vial after first use?
After the rubber septum is first punctured, store the vial at 2–8°C (refrigerator) and use within 28 days. Keep the vial away from direct light and do not freeze. Before drawing each dose, inspect the solution for particulates or cloudiness; discard the vial if either is present. The multi-dose vial format requires strict aseptic technique at every draw to prevent contamination. (2) angle_used

Manufacturer

Shelf-life integrity and formulation stability across the full 10ml vial service period — from first puncture to final draw — form the primary quality consideration Master Pharma addresses for the Ment SKU. The 100mg/ml Trestolone Acetate solution is formulated with carrier and co-solvent ratios verified to maintain uniform concentration and prevent crystallisation or precipitation within the vial across the stated storage temperature range of 2–25°C. Stability is not assumed from formulation design alone: each production batch clears reversed-phase HPLC potency verification, with the quantified result referenced against a certified external Trestolone Acetate standard and recorded on the lot Certificate of Analysis. LAL endotoxin testing provides a second independent release criterion. Together, these two analytical release gates ensure that the concentration and purity confirmed at the time of batch release remain representative of every dose drawn across the vial's in-use period — a material consideration for athletes running injection protocols spanning four to eight weeks from a single 10ml vial.

Product details

BrandMaster Pharma
Active ingredienttrestolone acetate
Also known asTrestolon, Trestolone, Ment 50, Ment, Master Pharma Trestolon
Strength100 mg
FormVial
Pack size1 piece
Item numberINJ-TRES-MAS-100-004

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Ment 50 50mg/ml 10ml Vial by Dragon-PharmaFast Acting

Ment 50 50mg/ml 10ml Vial by Dragon-Pharma

€56.00
MENT 50mg/ml 10x1ml Ampoules by Imperia LaboratoriesOptimal Dosage

MENT 50mg/ml 10x1ml Ampullen by Imperia Laboratories

€58.00
Trestolone Acetate 50mg/ml 10ml Vial by Magnus PharmaceuticalsHigh Concentration

Trestolone Acetate 50mg/ml 10ml Vial by Magnus Pharmaceuticals

€45.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00